FROVATRIPTAN SUCCINATE Drug Patent Profile
✉ Email this page to a colleague
When do Frovatriptan Succinate patents expire, and when can generic versions of Frovatriptan Succinate launch?
Frovatriptan Succinate is a drug marketed by Amneal Pharms Co, Glenmark Pharms Ltd, Mylan, and Renata. and is included in four NDAs.
The generic ingredient in FROVATRIPTAN SUCCINATE is frovatriptan succinate. There are three drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the frovatriptan succinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Frovatriptan Succinate
A generic version of FROVATRIPTAN SUCCINATE was approved as frovatriptan succinate by GLENMARK PHARMS LTD on March 11th, 2016.
Summary for FROVATRIPTAN SUCCINATE
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 4 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 42 |
Patent Applications: | 153 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in FROVATRIPTAN SUCCINATE? | FROVATRIPTAN SUCCINATE excipients list |
DailyMed Link: | FROVATRIPTAN SUCCINATE at DailyMed |
Pharmacology for FROVATRIPTAN SUCCINATE
Drug Class | Serotonin-1b and Serotonin-1d Receptor Agonist |
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for FROVATRIPTAN SUCCINATE
Paragraph IV (Patent) Challenges for FROVATRIPTAN SUCCINATE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
FROVA | Tablets | frovatriptan succinate | 2.5 mg | 021006 | 1 | 2011-03-09 |
US Patents and Regulatory Information for FROVATRIPTAN SUCCINATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amneal Pharms Co | FROVATRIPTAN SUCCINATE | frovatriptan succinate | TABLET;ORAL | 211292-001 | Nov 6, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Renata | FROVATRIPTAN SUCCINATE | frovatriptan succinate | TABLET;ORAL | 213891-001 | Apr 6, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Glenmark Pharms Ltd | FROVATRIPTAN SUCCINATE | frovatriptan succinate | TABLET;ORAL | 204730-001 | Mar 11, 2016 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Mylan | FROVATRIPTAN SUCCINATE | frovatriptan succinate | TABLET;ORAL | 202931-001 | Aug 28, 2014 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |